 SAN DIEGO, Jan. 26, 2021 GLOBE NEWSWIRE -- GBT Technologies Inc. OTC PINK: GTCH GBT, or the Company via GBT Tokenize Corp GBTTokenize , has started a series of improvements for its qTerm device as preparations for FDA certification process. The series of improvements are targeting higher measurements accuracy, reliability and compatibility with a broad spectrum of users usage behavior. qTerm is aimed to measure human vitals with a touch of a finger. Based on prototype testing, debugging and study, conclusions were made in order to increase the devices accuracy and stability as expected pre-requisites towards the companys intentions to file for FDA certification. There is no guarantee that the company or GBTTokenize will receive FDA certification for the qTerm. 